{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:04:27Z","timestamp":1791921867721,"version":"4.3.4"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>The aim was to study the pattern of adverse drug reaction (ADR) provoked by anticancer therapy and to assess the quality of life (QoL) in cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      This study was conducted in Tamil Nadu on 75 patients from February to July 2019 taking into account their demographic profile, ADR occurrence and its causality, outcome, organ system-wise distribution of ADRs, and others. The causality assessment was done by using Naranjo's scale and QoL was assessed by the Functional Assessment of Cancer Therapy-General (FACT-G) scale. The QoL was compared in any two consecutive cycles between the 2\n                      <jats:sup>nd<\/jats:sup>\n                      and 5\n                      <jats:sup>th<\/jats:sup>\n                      cycles of chemotherapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Out of the 75 patients, 17 male and 56 female patients developed ADR. A total of 228 ADRs were observed in 73 patients. The most commonly occurred ADR was nausea and vomiting (45%) and the most commonly affected system was gastrointestinal tract (37%). According to causality assessment, the ADR that occurred falls mostly in the category of probable (66.7%) followed by possible (29.3%) and the outcome of the ADR was mostly recovering (49.3%). The QoL was higher in females and in the age group of 40\u201349 years. The physical and emotional well-being of the patient were affected more. The overall QoL was improved in the 2\n                      <jats:sup>nd<\/jats:sup>\n                      visit when compared to the 1\n                      <jats:sup>st<\/jats:sup>\n                      visit.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Cancer is known to cause a significant impact on the health and socioeconomics of a nation. To boost the QoL in patients, it is essential to identify and manage the ADRs by taking appropriate measures to promote judicious use of drugs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_1015_19","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T03:13:21Z","timestamp":1623986001000},"page":"530-536","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["A prospective observational study of chemotherapy-induced adverse drug reaction and the quality of life in cancer patients in a tertiary care hospital"],"prefix":"10.4103","volume":"17","author":[{"given":"D.","family":"Krishnarajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Sivasakthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ariyamol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Naveen","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soniya","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-35-20241021","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2229-3485.154014","article-title":"Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care hospital in South India","volume":"6","author":"Sharma","year":"2015","journal-title":"Perspect Clin Res"},{"key":"R4-35-20241021","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4103\/0972-5229.175931","article-title":"Impact of clinical pharmacist in an Indian Intensive Care Unit","volume":"20","author":"Hisham","year":"2016","journal-title":"Indian J Crit Care Med"},{"key":"R5-35-20241021","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1470-2045(14)70115-9","article-title":"The growing burden of cancer in India: Epidemiology and social context","volume":"15","author":"Mallath","year":"2014","journal-title":"Lancet Oncol"},{"key":"R6-35-20241021","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1188\/06.ONF.S1.5-12","article-title":"Advances in how clinical nurses can evaluate and improve quality of life for individuals with cancer","volume":"33","author":"King","year":"2006","journal-title":"Oncol Nurs Forum"},{"key":"R7-35-20241021","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1477-7525-5-24","article-title":"Quality of life assessment in women with breast cancer: Benefits, acceptability and utilization","volume":"5","author":"Perry","year":"2007","journal-title":"Health Qual Life Outcomes"},{"key":"R8-35-20241021","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1586\/14737140.7.8.1123","article-title":"Quality of life and adjuvant systemic therapy for early-stage breast cancer","volume":"7","author":"Grimison","year":"2007","journal-title":"Expert Rev Anticancer Ther"},{"key":"R9-35-20241021","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40780-018-0105-3","article-title":"Impact of pharmacist counseling on reducing instances of adverse events that can affect the quality of life of chemotherapy outpatients with breast Cancer","volume":"4","author":"Tanaka","year":"2018","journal-title":"J Pharm Health Care Sci"},{"key":"R10-35-20241021","first-page":"71","article-title":"Chemotherapy induced adverse drug reactions in cancer patients","volume":"8","author":"Mugada","year":"2017","journal-title":"Int J Pharma Res"},{"key":"R11-35-20241021","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5530\/ijopp.10.4.55","article-title":"Assessment of adverse effect of most commonly prescribed anticancer drugs in a tertiary care teaching hospital","volume":"10","author":"Sunny","year":"2017","journal-title":"Indian J Pharm Practice"},{"key":"R12-35-20241021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15226\/2476-2431\/2\/1\/00114","article-title":"Adverse drug reaction due to cancer chemotherapy and its financial burden in different hospitals of Nepal","volume":"2","author":"Shrestha","year":"2017","journal-title":"Int J Pharmacovigilance"},{"key":"R13-35-20241021","doi-asserted-by":"crossref","first-page":"215","DOI":"10.22159\/ajpcr.2018.v11i6.24849","article-title":"A prospective study of adverse drug reactions due to platinum analogs \u2013 Chemotherapy in a tertiary care hospital","volume":"11","author":"Kumar","year":"2018","journal-title":"Asian J Pharm Clin Res"},{"key":"R14-35-20241021","first-page":"2","article-title":"Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospital in Eastern India","volume":"1","author":"\u00a9Prasad","year":"2013","journal-title":"J Pharmacovigilance"},{"key":"R15-35-20241021","first-page":"89","article-title":"A study of adverse drug reactions in cancer patients due to chemotherapy in a tertiary care hospital, rims, Ranchi","volume":"16","author":"Keshri","year":"2017","journal-title":"IOSR J Dent Med Sci (IOSR-JDMS"},{"key":"R16-35-20241021","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/0971-5851.177015","article-title":"Chemotherapy induced adverse drug reactions in oncology patients: A prospective observational study","volume":"37","author":"Chopra","year":"2016","journal-title":"Indian J Med PaediatrOncol"},{"key":"R17-35-20241021","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/02841860310023453","article-title":"Normative data for functional assessment of cancer therapy\u2014general scale and its use for the interpretation of quality of life scores in cancer survivors","volume":"43","author":"Holzner","year":"2004","journal-title":"Acta Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1015_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:37:48Z","timestamp":1787067468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1015_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1015_19","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}